Phoresa


Developer of high-sensitivity point-of-care diagnostic tests for infectious diseases. Uses electrokinetic preconcentration and custom assay chemistry on paper-based formats to improve detection limits of lateral-flow-style assays and translate laboratory assays into clinic-ready, rapid tests.

Industries

health-care
medical
pharmaceutical

Nr. of Employees

small (1-50)

Phoresa

Seattle, Washington, United States, North America


Products

High-sensitivity point-of-care diagnostic tests for infectious diseases

Lateral-flow-style, in-clinic diagnostic tests that use electrokinetic preconcentration and assay chemistry to lower detection limits and increase clinical sensitivity for infection targets.


Services

Collaborative partnerships for diagnostic development

Engagements to discuss technology questions or potential co-development and partnership opportunities for point-of-care diagnostic projects.

Expertise Areas

  • Point-of-care diagnostics
  • Assay development for infectious diseases
  • Paper-based microfluidics
  • Electrokinetic preconcentration (isotachophoresis)
  • Show More (3)

Key Technologies

  • Isotachophoresis / electrokinetic preconcentration
  • Paper-based microfluidics
  • Lateral-flow-style immunoassays
  • Immunoassay chemistry
  • Show More (2)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.